Akums Drugs and Pharmaceuticals Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: AKUMS BSE: 544222

About Akums Drugs and Pharmaceuticals Limited

Akums Drugs and Pharmaceuticals Limited (Akums Group) is an Indian pharmaceutical Contract Development and Manufacturing Organization (CDMO) that serves both domestic and multinational pharmaceutical companies. The company was established in 2004 and became publicly listed on 6 August 2024.

Source: Wikipedia

Key facts

BSE symbol544222
NSE symbolAKUMS
ISININE09XN01023
CINL24239DL2004PLC125888
Listing date6 Aug 2024
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorM/s. SPG & Associates (Atul Kumar Rawat)
Registered office304, 3rd Floor, Mohan Place, L.S.C, Block-C, Saraswati Vihar, New Delhi ��� 110034

Financial performance

Full financials →
Fiscal yearMar 26Mar 25
Total income (before exceptional items)1,462†1,436†
Net profit112161

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
Sandeep JainExecutive DirectorJune 30, 2026
Sanjay SinhaExecutive DirectorJune 30, 2026
Sanjeev JainExecutive DirectorJune 30, 2026
Anil AminIndependent DirectorJune 30, 2026
Kewal Kundanlal HandaIndependent DirectorJune 30, 2026
Matangi GowrishankarIndependent DirectorJune 30, 2026
Satwinder SinghIndependent DirectorJune 30, 2026
Sunil Kumar ThakurNon-Executive Director,Nominee DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.